Study Overview: This clinical study is testing a new medicine called IMP7068 for patients with advanced solid tumors, a type of cancer that forms in body tissues. The study is in its first phase, which means it's mainly about checking how safe the medicine is and how it moves through the body. It involves two parts: one to find the best dose and another to see how well it works against tumors.

• The study will have about 140-350 patients, and it might involve taking the medicine and regular check-ups.
• Participants need to be adults (18 or older) and must have a type of tumor that doesn't respond to usual treatments.
• People with certain health issues, like untreated brain cancer, serious infections, or those who can't take pills, can't join.

Note: Joining a study means you might help doctors learn more about the medicine, but it could come with risks like side effects. Always talk to your doctor to understand if it's right for you.